Insulin Aspart Injection, Solution
Product Images NDC 70518-3865

1 FDA label image from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Insulin Aspart (NDC 70518-3865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Insulin Aspart Flexpen 100 Units mL(u 100) 70518 3865 00)

Mm1 (Insulin Aspart Flexpen 100 Units   mL(u 100) 70518 3865 00)
Insulin Aspart FlexPen Prefilled Syringe label showing 100 Units/mL (U-100) strength. The package contains 5 pens, each 3 mL. Label includes NDC 70518-3865-00, indicates Rx only, and repackaged by RemedyRepack Inc. Usage and storage warnings are present, with manufacturer details for Novo Nordisk Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.